Cutler Group LP Virios Therapeutics, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

A detailed history of Cutler Group LP transactions in Virios Therapeutics, Inc. stock. As of the latest transaction made, Cutler Group LP holds 2,300 shares of VIRI stock, worth $10,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,300
Previous 2,300 -0.0%
Holding current value
$10,212
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 07, 2023
BUY
$0.24 - $0.39 $264 - $429
1,100 Added 91.67%
2,300 $0
Q3 2022

Oct 25, 2022
BUY
$0.37 - $8.77 $444 - $10,524
1,200 New
1,200 $0

Others Institutions Holding VIRI

# of Institutions
4
Shares Held
36.1K
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email